Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy
- PMID: 15522014
- DOI: 10.1111/j.1469-0691.2004.00982.x
Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy
Abstract
Among shigellas isolated from patients in England and Wales in 2002, 10% of subgroups A, B and C, and 13% of subgroup D (Shigella sonnei), were resistant to nalidixic acid. As a consequence, should antimicrobial therapy be indicated, the efficacy of nalidixic acid as the preferred treatment for children with bacillary dysentery has been jeopardised.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
